Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ucci

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Acta Haematologica|January 1, 1987
Abnormalities of T cell subsets in a patient with cyclic neutropeniaG Ucci, M Danova, A Riccardi, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1986
Peptichemio, vincristine and prednisone versus melphalan and prednisone as induction therapy in multiple myelomaA Riccardi, G Merlini, C Montecucco, et al.
Haematologica|March 1, 1984
Proliferative activity, response to therapy and survival in multiple myelomaA Riccardi, C Montecucco, G Merlini, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Changing clinical presentation of multiple myelomaA Riccardi, P G Gobbi, G Ucci, et al.
Cancer|March 15, 1992
Serum thymidine kinase in monoclonal gammopathies. A prospective study. The Cooperative Group for Study and Treatment of Multiple MyelomaR Luoni, G Ucci, A Riccardi, et al.
Hematological Oncology|May 1, 1992
Expression of p170 protein in multiple myeloma: a clinical studyG Ucci, M Petrini, A Riccardi, et al.
Haematologica|January 1, 1988
Serum thymidine kinase in hematologic malignanciesR Luoni, G Ucci, A Riccardi, et al.
Acta Haematologica|January 1, 1986
Analysis of human myeloma cell population kineticsC Montecucco, A Riccardi, G Ucci, et al.
Oncology Reports|May 21, 2011
Advanced breast-cancer - a randomized study of different doses of epirubicin associated with fixed doses of cyclophosphamide and 5-FluorouracilA Riccardi, M Giordano, S Brugnatelli, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Different doses of epirubicin associated with fixed doses of cyclophosphamide and 5-fluorouracil: a randomised study in advanced breast cancerA Riccardi, M Giordano, S Brugnatelli, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Acta Haematologica|January 1, 1987
Abnormalities of T cell subsets in a patient with cyclic neutropeniaG Ucci, M Danova, A Riccardi, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1986
Peptichemio, vincristine and prednisone versus melphalan and prednisone as induction therapy in multiple myelomaA Riccardi, G Merlini, C Montecucco, et al.
Haematologica|March 1, 1984
Proliferative activity, response to therapy and survival in multiple myelomaA Riccardi, C Montecucco, G Merlini, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Changing clinical presentation of multiple myelomaA Riccardi, P G Gobbi, G Ucci, et al.
Cancer|March 15, 1992
Serum thymidine kinase in monoclonal gammopathies. A prospective study. The Cooperative Group for Study and Treatment of Multiple MyelomaR Luoni, G Ucci, A Riccardi, et al.
Hematological Oncology|May 1, 1992
Expression of p170 protein in multiple myeloma: a clinical studyG Ucci, M Petrini, A Riccardi, et al.
Haematologica|January 1, 1988
Serum thymidine kinase in hematologic malignanciesR Luoni, G Ucci, A Riccardi, et al.
Acta Haematologica|January 1, 1986
Analysis of human myeloma cell population kineticsC Montecucco, A Riccardi, G Ucci, et al.
Oncology Reports|May 21, 2011
Advanced breast-cancer - a randomized study of different doses of epirubicin associated with fixed doses of cyclophosphamide and 5-FluorouracilA Riccardi, M Giordano, S Brugnatelli, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Different doses of epirubicin associated with fixed doses of cyclophosphamide and 5-fluorouracil: a randomised study in advanced breast cancerA Riccardi, M Giordano, S Brugnatelli, et al.
Pageof 8